Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Urology-Nephrology
»
Neoplasia/BPH
10. May 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Anzeige
Zoom:
Page 1 of 9386
Articles 1 - 20 / 187707
Comparative Efficacy of First-Line Immune Checkpoint Inhibitor-Based Combination Therapies in Patients With Sarcomatoid Renal Cell Carcinoma: A Japanese Multicenter Cohort Study.
Int J Urol
Tamura K, Matsushita Y, Watanabe H, Yanagisawa T, Mori K, Morinaka H, Bekku K, Toyoda S, Nukaya T, Maenosono R, Komura K, Araki M, Fujita K, Takahara K, Azuma H, Inamoto T.
PMID: 42106902 [PubMed - indexed for MEDLINE]
Detection of bladder cancer in patients with microscopic hematuria using Oncuria-Detect: results of a prospective, multicenter international study.
J Transl Med
Lotan Y, Anai S, Kim H, Gin G, Akhavein A, Miyake M, Luu M, Ahdoot M, Messing E, Peers G, Chen A, Moradzadeh A, Chin AI, Liu M, Tanaka S, Tikhonekov S, Pagano I, Zheng Y, Zhang Z, Furuya H, Rosser CJ.
PMID: 42106837 [PubMed - as supplied by publisher]
Proclarix' performance in ruling out patients with no or indolent prostate cancer: evaluation in a Danish population.
BMC Cancer
Schiess R, Athanasiou A, Kasten MME, Hansen TF, Kissow GE, Obro LF, Madsen JS, Poulsen MH, Osther PJ, Zedan AH.
PMID: 42106678 [PubMed - as supplied by publisher]
10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial.
Eur Urol
Meier RM, Aghdam N, Beckman AC, Woodhouse SA, Williamson SK, Mohideen N, Dombrowski JJ, Kaplan ID.
PMID: 42106276 [PubMed - as supplied by publisher]
Advanced nanomedicines to target prostate cancer cells: emerging molecular tools and future clinical prospects.
Int J Pharm
Abboud O, Sohail M.
PMID: 42105963 [PubMed - as supplied by publisher]
Integrated (68)Ga-PSMA PET/MRI models improve prostate cancer diagnosis and ISUP stratification, especially in the low-PSA cohort.
EJNMMI Res
Dai Z, Lv Y, Ruan W, Gai Y, Lan X, Qin C.
PMID: 42105178 [PubMed - as supplied by publisher]
From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
Drugs Real World Outcomes
Bosch D, van der Velden KJM, Beeker A, van den Berg HP, Bergman AM, van der Doelen MJ, van den Eertwegh AJM, Hendriks MP, Kerkhofs TMA, van de Luijtgaarden ACM, Mehra N, van Moorselaar RJA, Tascilar M, Vervenne WL, Weijl NI, Uyl-de Groot CA, Mulders PFA, Kuppen MCP, van Oort IM.
PMID: 42105061 [PubMed - as supplied by publisher]
The Effect of Refined Nursing on Postoperative Recovery and Inflammatory Cytokine Levels in Patients Undergoing Radical Prostatectomy for Prostate Cancer.
Arch Esp Urol
Liu S, Zhai X.
PMID: 42104707 [PubMed - indexed for MEDLINE]
Risk Stratification of Suspected Clinically Localized Prostate Cancer Using Multi-Indicator Functional Differentiation: A Predictive Model With fPSA/tPSA, PHI, PCA3, and MRI.
Arch Esp Urol
Li L, Xu Y, Chen M.
PMID: 42104706 [PubMed - indexed for MEDLINE]
Predictors of BCG Therapy Complications in Non-Muscle-Invasive Bladder Cancer: A Clavien-Dindo-Based Study.
Arch Esp Urol
Turan T, Efiloglu O, Hamidzada I, Ahmadzada J, Polat S, Yildirim A.
PMID: 42104704 [PubMed - indexed for MEDLINE]
Correlation of Serum Adiponectin and Metabolic Syndrome Components With Prostate Cancer Susceptibility and Construction of a Nomogram Prediction Model.
Arch Esp Urol
Cheng L, Zhou X, Pan J, Xing Y, Fu J, Zhang W, Zhang Z.
PMID: 42104702 [PubMed - indexed for MEDLINE]
Heart Rate Variability as a Novel Indicator for Predicting Postoperative Urinary Retention in Benign Prostatic Hyperplasia: Development and Internal Validation of a Predictive Nomogram.
Arch Esp Urol
Qin Y, Song X, Zhang W, Chen B.
PMID: 42104701 [PubMed - indexed for MEDLINE]
Genetically Predicted Gut Microbiota and Bladder Cancer Risk: A Mendelian Randomisation Analysis.
Arch Esp Urol
Wei F, Zhao M, Sun X, Ma H, Yin H, Shen X, Chen S.
PMID: 42104697 [PubMed - indexed for MEDLINE]
Association of Inflammatory and Nutritional Biomarkers with Pathological Response in Patients with Muscle-invasive Bladder Carcinoma Treated with Neoadjuvant Chemotherapy.
Arch Esp Urol
Navarro-Jiménez S, Carrión-López P, Lorenzo-Sánchez MV, Tárraga-Honrubia MA, Díaz-de-Mera-Sánchez-Migallón I, Giménez-Bachs JM, Salinas-Sánchez AS.
PMID: 42104694 [PubMed - indexed for MEDLINE]
Development of a Novel Nomogram to Predict Biochemical Failure and Prostate Cancer-Specific Mortality After Definitive Radiotherapy in Patients with Gleason Score 7 Prostate Cancer.
Arch Esp Urol
Elmal A, Demirhan B, Senturk E, Guler OC, Erpolat P, Onal C.
PMID: 42104693 [PubMed - indexed for MEDLINE]
Comparative Analysis of Greenlight Laser Photovaporization and Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia Surgery.
Arch Esp Urol
García Rico E, Ortega Polledo LE, Sánchez Pellejero A, Bianchini Hernández G, Gómez Rivas J, Sanchis Bonet A, Galante Romo I, Moreno Sierra J, Alonso Y Gregorio S.
PMID: 42104692 [PubMed - indexed for MEDLINE]
Current Evidence on the Use of Cystoscopy in the Follow-up of Non-Muscle-Invasive Bladder Cancer: Are We Overusing It? Systematic Review of the Literature.
Arch Esp Urol
Baudet León J, Caño Velasco J, Polanco Pujol L, Artero Fullana S, Pastor Rodenas B, Subiela Henriquez JD, García Martín LA, Hernández Fernández C, Bielsa Carrillo A.
PMID: 42104689 [PubMed - indexed for MEDLINE]
Risk Assessment of Non-Urinary Tract Recurrence After Radical Nephroureterectomy Based on CheckMate 274 Trial Eligibility: A Multicenter Retrospective Study.
Int J Urol
Shindo T, Ueki Y, Muranaka I, Kobayashi G, Miyamoto S, Kunishima Y, Sato S, Okada M, Kato S, Kato R, Adachi H, Matsukawa M, Takayanagi A, Shibamori K, Wanifuchi A, Kyoda Y, Hashimoto K, Kobayashi K, Tanaka T, Masumori N.
PMID: 42104674 [PubMed - indexed for MEDLINE]
The low-grade Inflammation Score (INFLA-Score) as a predictor of overall survival in prostate cancer: a UK biobank cohort study.
BMC Urol
Jiang S, Zheng X, Qiu H, Tao N, An H.
PMID: 42104304 [PubMed - as supplied by publisher]
The combination of atezolizumab and BCG in high-risk non-muscle invasive bladder cancer: results of the phase Ib/II BladderGATE clinical trial.
Oncologist
Guerrero-Ramos F, Gómez-Cañizo C, Rodríguez-Izquierdo M, Hernández-Arroyo M, Rodríguez-Antolín A, de Velasco G, Ponce-Aix S, Paramio JM, Suárez-Cabrera C, Rubio C, Morales L, García-Martínez V, Dueñas M, Castellano D.
PMID: 42103978 [PubMed - as supplied by publisher]
Articles 1 - 20 / 187707
Page 1 of 9386
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy